Journal Article
. 2017 Jul; 7(1):3-5.
doi: 10.3892/br.2017.922.

Personalized medicine could transform healthcare

Sunil Mathur 1 Joseph Sutton 1 
  • PMID: 28685051
  •     15 References
  •     18 citations


Personalized medicine (PM) is about tailoring a treatment as individualized as the disease. The approach relies on identifying genetic, epigenomic, and clinical information that allows the breakthroughs in our understanding of how a person's unique genomic portfolio makes them vulnerable to certain diseases. PM approach is a complete extension of traditional approach (One-Size-Fits-All) to increasing our ability to predict which medical treatments will be safe and effective for individual patient, and which ones will not be, based on the patient's unique genetic profile. Implementation of PM has the potential to reduce financial and time expenditure, and increase quality of life and life extension of patients. Knowledge of PM facilitates earlier disease detection via enhanced use of existing biomarkers and detection of early genomic and epigenomic events in disease development, particularly carcinogenesis. The PM approach predominantly focuses on preventative medicine and favours taking pro-active actions rather than just reactive. This approach delays or prevents the need to apply more severe treatments which are usually less tolerated and with increased quality of life and financial considerations. Increasing healthcare costs have placed additional pressure on government funded healthcare systems globally, especially regarding end of life care. PM may increase the effectiveness of existing treatments and negate the inherent problems associated with non-PM approaches. PM is a young but rapidly expanding field of healthcare where a physician can select a treatment based on a patient's genetic profile that may not only minimize harmful side effects and guarantee a more successful result, but can be less cost effective compared with a 'trial-and-error' approach to disease treatment. The less efficient non-PM ('trial-and-error') approach, which can lead to drug toxicity, severe side effects, reactive treatment and misdiagnosis continue to contribute to increasing healthcare costs. Increased patient stratification will allow for the enhanced application of PM and pro-active treatment regimens, resulting in reduced costs and quality of life enhancement.

Keywords: personalized medicine; tailored therapy; target therapy.

The digital code of DNA.
Leroy Hood, David Galas.
Nature, 2003 Jan 24; 421(6921). PMID: 12540920
Pharmacogenetics/genomics and personalized medicine.
Wolfgang Sadée, Zunyan Dai.
Hum Mol Genet, 2005 Oct 26; 14 Spec No. 2. PMID: 16244319
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?
Muin J Khoury, Marta Gwinn, +3 authors, Linda Bradley.
Genet Med, 2007 Dec 13; 9(10). PMID: 18073579
Highly Cited. Review.
The path to personalized medicine.
Margaret A Hamburg, Francis S Collins.
N Engl J Med, 2010 Jun 17; 363(4). PMID: 20551152
Highly Cited.
Personalized medicine: part 1: evolution and development into theranostics.
F Randy Vogenberg, Carol Isaacson Barash, Michael Pursel.
P T, 2010 Nov 03; 35(10). PMID: 21037908    Free PMC article.
Personalized medicine: part 2: ethical, legal, and regulatory issues.
F Randy Vogenberg, Carol Isaacson Barash, Michael Pursel.
P T, 2010 Dec 09; 35(11). PMID: 21139819    Free PMC article.
Cancer immunotherapy: sipuleucel-T and beyond.
Aimee E Hammerstrom, Diana H Cauley, Bradley J Atkinson, Padmanee Sharma.
Pharmacotherapy, 2011 Sep 20; 31(8). PMID: 21923608    Free PMC article.
Trastuzumab: updated mechanisms of action and resistance in breast cancer.
Thuy Vu, Francois X Claret.
Front Oncol, 2012 Jun 22; 2. PMID: 22720269    Free PMC article.
Highly Cited.
Cas9 as a versatile tool for engineering biology.
Prashant Mali, Kevin M Esvelt, George M Church.
Nat Methods, 2013 Oct 01; 10(10). PMID: 24076990    Free PMC article.
Highly Cited. Review.
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study.
Mariam Jamal-Hanjani, Alan Hackshaw, +68 authors, Charles Swanton.
PLoS Biol, 2014 Jul 09; 12(7). PMID: 25003521    Free PMC article.
Highly Cited.
Active surveillance for prostate cancer.
Javier Romero-Otero, Borja García-Gómez, +4 authors, Karim A Touijer.
Int J Urol, 2015 Dec 02; 23(3). PMID: 26621054    Free PMC article.
Systematic Review.
MABS: targeted therapy tailored to the patient's need.
Yasser El Miedany.
Br J Nurs, 2016 Mar 08; 24(16 Suppl 1). PMID: 26946646
CRISPR gene-editing tested in a person for the first time.
David Cyranoski.
Nature, 2016 Nov 25; 539(7630). PMID: 27882996
Highly Cited.
Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Jonathan C M Wan, Charles Massie, +6 authors, Nitzan Rosenfeld.
Nat Rev Cancer, 2017 Feb 25; 17(4). PMID: 28233803
Highly Cited. Review.
US FDA and personalized medicine: in vitro diagnostic regulatory perspective.
Živana Težak, Marina V Kondratovich, Elizabeth Mansfield.
Per Med, 2010 Sep 01; 7(5). PMID: 29776248
From hype to reality: data science enabling personalized medicine.
Holger Fröhlich, Rudi Balling, +17 authors, Blaz Zupan.
BMC Med, 2018 Aug 28; 16(1). PMID: 30145981    Free PMC article.
The AKR1D1*36 (rs1872930) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome.
Aleksandra Kapedanovska-Nestorovska, Aleksandar J Dimovski, +5 authors, Rodney Rosalia.
Pharmgenomics Pers Med, 2019 Nov 07; 12. PMID: 31695473    Free PMC article.
Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia.
L Renee Ruhaak, Arnoud van der Laarse, Christa M Cobbaert.
Ann Clin Biochem, 2019 Mar 21; 56(3). PMID: 30889974    Free PMC article.
The decision tool unipolar depression (DTUD): a new measure to facilitate the early identification of patients with major depressive disorder in need of highly specialized care.
Frédérique C W van Krugten, Maartje Goorden, +6 authors, Decision Tool Unipolar Depression Consortium.
BMC Psychiatry, 2019 Jun 13; 19(1). PMID: 31185975    Free PMC article.
Using NGS-methylation profiling to understand the molecular pathogenesis of young MI patients who have subsequent cardiac events.
Michelle Thunders, Ana Holley, +2 authors, Peter Larsen.
Epigenetics, 2019 Apr 12; 14(6). PMID: 30971167    Free PMC article.
The nuts and bolts of omics for the clinical allergist.
Yamini V Virkud, Rachel S Kelly, Caleb Wood, Jessica A Lasky-Su.
Ann Allergy Asthma Immunol, 2019 Sep 29; 123(6). PMID: 31562939    Free PMC article.
A Feasibility Study of an Extrusion-Based Fabrication Process for Personalized Drugs.
Ilhan Yu, Roland K Chen.
J Pers Med, 2020 Mar 08; 10(1). PMID: 32143471    Free PMC article.
Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.
Jan Schjøtt.
EPMA J, 2019 Jul 02; 10(2). PMID: 31258816    Free PMC article.
Proteostasis and Proteotoxicity in the Network Medicine Era.
Marta Lualdi, Tiziana Alberio, Mauro Fasano.
Int J Mol Sci, 2020 Sep 10; 21(17). PMID: 32899160    Free PMC article.
A Network-Based Mixed Methods Approach to Analyze Current Perspectives on Personalized Oncological Medicine in Austria.
Ines Viktoria Stelzer, Anna Sierawska, Alena Buyx, Judit Simon.
J Pers Med, 2020 Dec 17; 10(4). PMID: 33322735    Free PMC article.
Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review.
Anne Dietz, Maria Gomolka, Simone Moertl, Prabal Subedi.
J Pers Med, 2020 Dec 31; 11(1). PMID: 33375047    Free PMC article.
3D Printing as a Promising Tool in Personalized Medicine.
Vanessa Marcia Vaz, Lalit Kumar.
AAPS PharmSciTech, 2021 Jan 19; 22(1). PMID: 33458797    Free PMC article.
Survival outcomes are associated with genomic instability in luminal breast cancers.
Lydia King, Andrew Flaus, Emma Holian, Aaron Golden.
PLoS One, 2021 Feb 04; 16(2). PMID: 33534788    Free PMC article.
Differentiating Neuroblastoma: A Systematic Review of the Retinoic Acid, Its Derivatives, and Synergistic Interactions.
Nadiya Bayeva, Erin Coll, Olga Piskareva.
J Pers Med, 2021 Apr 04; 11(3). PMID: 33809565    Free PMC article.
Kinetic Release Studies of Antibiotic Patches for Local Transdermal Delivery.
Esra Altun, Esra Yuca, +5 authors, Oguzhan Gunduz.
Pharmaceutics, 2021 May 01; 13(5). PMID: 33922739    Free PMC article.
Targeting epigenetic regulatory machinery to overcome cancer therapy resistance.
Lei Guo, Yi-Tsang Lee, Yubin Zhou, Yun Huang.
Semin Cancer Biol, 2021 Jan 10;. PMID: 33421619    Free PMC article.
Mass spectrometry based high-throughput bioanalysis of low molecular weight compounds: are we ready to support personalized medicine?
Sophie Bravo-Veyrat, Gérard Hopfgartner.
Anal Bioanal Chem, 2021 Aug 24;. PMID: 34424372
Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial.
Jun Liu, Dan-Dan Li, +77 authors, Zhong Wang.
Signal Transduct Target Ther, 2021 Sep 03; 6(1). PMID: 34471087